-
-
-
-
-
-
-
Humacyte receives DoD funding for bioengineered blood vessel procurement
-
-
-
-
-
-
-
Estrella Immunopharma reports positive phase 1 data for cancer therapy
-
-
-
-
-
-
-
FDA moves to restrict copycat GLP-1 weight loss drugs
-
-
-
-
-
-
-
Priovant reports positive Phase 2 results for brepocitinib in skin condition
-
-
-
-
-
-
-
FDA allows 'no artificial colors' claims for foods without petroleum-based dyes
-
-
-
-
-
-
-
Mirum Pharmaceuticals receives Health Canada approval for LIVMARLI treatment
-
-
-
-
-
-
-
Arcellx presents data on anito-cel binder specificity at TANDEM meeting
-
73,953 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.

